Literature DB >> 9227330

CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.

C E Cross1, H L Collins, G J Bancroft.   

Abstract

Phagocytosis is a fundamental process in innate resistance to infection. We have used the pathogenic yeast Cryptococcus neoformans to study the interaction of this encapsulated organism with murine macrophages in vitro. In the absence of exogenous opsonins the encapsulated yeast is almost totally resistant to ingestion by murine macrophages. Owing to its ability to activate the alternative complement pathway, the anti-phagocytic properties of the polysaccharide capsule can be partially overcome following opsonization in vitro with non-immune mouse serum and subsequent phagocytosis via complement receptors. Here, we demonstrate the importance of the complement receptor type 3 (CR3) in in vitro phagocytosis of the yeast and in in vivo resistance to infection. In vitro, 70% of a population of resident murine macrophages are able to ingest C. neoformans and then only inefficiently (1-2 organisms per cell). Previously we have shown that tumour necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF) efficiently enhance ingestion of serum-opsonized encapsulated C. neoformans, and we now show that the cytokines convert a population of resident macrophages to a state where all the cells are competent for ingestion of large numbers of yeasts (6-8 per cell). We also show that these cytokines have a direct effect on CR3, as enhanced levels of complement-opsonized sheep red blood cells (EIgMC) bind to macrophages activated in this way. However, cytokines that have previously been shown to enhance phagocytosis of EIgMC have no effect on ingestion of encapsulated C. neoformans. These results demonstrate that the cytokines regulating CR3-dependent ingestion of C. neoformans are different to those regulating ingestion of EIgMC and reinforce the importance of studying pathogens rather than inert ligands in understanding the regulation of phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227330      PMCID: PMC1363860          DOI: 10.1046/j.1365-2567.1997.00238.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils.

Authors:  M Berger; E M Wetzler; R S Wallis
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

2.  Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes.

Authors:  M E Wilson; R D Pearson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

3.  Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.

Authors:  T R Kozel; G S Pfrommer; A S Guerlain; B A Highison; G J Highison
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

4.  Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.

Authors:  G D Ross; J A Cain; P J Lachmann
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors.

Authors:  I L Graham; H D Gresham; E J Brown
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

6.  Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

7.  Phorbol esters cause sequential activation and deactivation of complement receptors on polymorphonuclear leukocytes.

Authors:  S D Wright; B C Meyer
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

8.  Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.

Authors:  E Neuman; J W Huleatt; R M Jack
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

9.  Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.

Authors:  H Rosen; S Gordon
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

10.  Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells.

Authors:  H Rosen; S Gordon; R J North
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

View more
  14 in total

1.  A new assay to monitor the degranulation process in phagocytizing human neutrophils.

Authors:  Violetta Borelli; Maria Giovanna Perrotta; Francesca Vita; Maria Rosa Soranzo; Giuliano Zabucchi
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  Fungal pathogen recognition by scavenger receptors in nematodes and mammals.

Authors:  Terry K Means
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 4.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

5.  Host defence to pulmonary mycosis.

Authors:  C H Mody; P W Warren
Journal:  Can J Infect Dis       Date:  1999-03

6.  Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans.

Authors:  André Moraes Nicola; Patrícia Albuquerque; Luis R Martinez; Rafael Antonio Dal-Rosso; Carolyn Saylor; Magdia De Jesus; Joshua D Nosanchuk; Arturo Casadevall
Journal:  Infect Immun       Date:  2012-06-18       Impact factor: 3.441

7.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

8.  Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.

Authors:  Dale Netski; Thomas R Kozel
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

9.  The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Authors:  Richard W Stokes; Raymond Norris-Jones; Donald E Brooks; Terry J Beveridge; Dan Doxsee; Lisa M Thorson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  App1: an antiphagocytic protein that binds to complement receptors 3 and 2.

Authors:  Paola Stano; Virginia Williams; Maristella Villani; Eugene S Cymbalyuk; Asfia Qureshi; Yuxiang Huang; Giulia Morace; Chiara Luberto; Stephen Tomlinson; Maurizio Del Poeta
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.